[Partial resistance to acenocoumarol and phenprocoumon caused by enzyme polymorphism].
Niermeijer
M F
MF
D000074:Acenocoumarol / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D004351:Drug Resistance; D006801:Humans; D006899:Mixed Function Oxygenases / Q000235:genetics*; D009154:Mutation; D010644:Phenprocoumon / Q000627:therapeutic use; D011110:Polymorphism, Genetic; D064417:Vitamin K Epoxide Reductases
D000925:Anticoagulants; D006899:Mixed Function Oxygenases; D064417:Vitamin K Epoxide Reductases; D000074:Acenocoumarol; D010644:Phenprocoumon